Cargando…
Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323
Arthropod-borne flavivirus infection continues to cause significant morbidity and mortality worldwide. Identification of drug targets and novel antiflaviviral compounds to treat these diseases has become a global health imperative. A previous screen of 235,456 commercially available small molecules...
Autores principales: | Bullard, Kristen M., Gullberg, Rebekah C., Soltani, Elnaz, Steel, J. Jordan, Geiss, Brian J., Keenan, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468182/ https://www.ncbi.nlm.nih.gov/pubmed/26075394 http://dx.doi.org/10.1371/journal.pone.0130083 |
Ejemplares similares
-
Oxidative stress influences positive strand RNA virus genome synthesis and capping
por: Gullberg, Rebekah C., et al.
Publicado: (2015) -
A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme
por: Bullard-Feibelman, Kristen M., et al.
Publicado: (2016) -
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
por: Celegato, Marta, et al.
Publicado: (2023) -
Flaviviral Replication Complex: Coordination between RNA Synthesis and 5′-RNA Capping
por: Klema, Valerie J., et al.
Publicado: (2015) -
Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection
por: Pathak, Nikhil, et al.
Publicado: (2017)